Inventiva S.A. (NASDAQ:IVA - Get Free Report) shares traded down 2.8% on Tuesday . The stock traded as low as $2.11 and last traded at $2.11. 5,585 shares changed hands during trading, an increase of 7% from the average session volume of 5,223 shares. The stock had previously closed at $2.17.
Analysts Set New Price Targets
IVA has been the topic of a number of research reports. UBS Group began coverage on shares of Inventiva in a report on Tuesday, November 12th. They set a "neutral" rating and a $3.00 target price on the stock. Stifel Nicolaus lowered their target price on Inventiva from $20.00 to $17.00 and set a "buy" rating for the company in a research note on Friday, November 22nd. Finally, HC Wainwright reduced their price target on Inventiva from $14.00 to $13.00 and set a "buy" rating on the stock in a research report on Tuesday, October 15th.
Get Our Latest Report on IVA
Inventiva Trading Down 2.8 %
The company has a 50-day moving average price of $2.46 and a 200-day moving average price of $2.39.
About Inventiva
(
Get Free Report)
Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.
Read More
Before you consider Inventiva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inventiva wasn't on the list.
While Inventiva currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
